Research output

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • trastuzumab, cost-effectiveness, early breast cancer, real-world, Markov model, RANDOMIZED CONTROLLED-TRIAL, ECONOMIC EVALUATIONS, MODEL, CHEMOTHERAPY, THERAPY, IMPACT, HERA
View graph of relations

Details

Original languageEnglish
Pages (from-to)79223-79233
Number of pages11
JournalOncotarget
Volume8
Issue number45
DOIs
Publication statusPublished - 3 Oct 2017